Thousands of lives potentially saved and hospital costs reduced are the predicted outcomes if more hospitals adopt certain quality measures on a wider scale, according to an analysis by Premier Inc. healthcare alliance, headquartered in San Diego, which is owned by more than 200 of the nation's leading not-for-profit hospitals and healthcare systems.
Siemens completed its acquisition of Diagnostic Products Corp. (DPC) in late July, marking a significant milestone for Siemens as it enters the in-vitro diagnostics (IVD) market. Together with DPC, Siemens Medical Solutions says it will become the first full service diagnostics company.
It may seem like a simple concept, but the importance of properly controlled patient temperature is still surprising ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
The Relay 250-mm thoracic stent-graft is commercially available in Europe in both straight and taper configurations. The ...
The EXCOR TAH-t has received CE approval with the CardioWest TAH-t. The pneumatic drivers provide precisely calibrated ...
The Philips integrated cath lab is a solution featuring integrated technologies designed to improve productivity and throughput.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
At a pivotal time of advancement in cardiovascular imaging, diagnostics, interventions and therapies, a time when specialty heart hospitals are forming to combat the deadliest disease in America, the federal purse strings are about to be pulled a little tighter in 2007, and rules for these types of narrowly focused hospitals are going to be more stringent.
While enormous pressure may be the norm for cardiac surgeons, the stakes are particularly high when the life of a former U.S. president is on the line. And when Bill Clinton underwent quadruple bypass surgery in 2004, all eyes were on the heart specialists at NewYork-Presbyterian Hospital in New York City.
The Atlas II ICD (implantable cardioverter defibrillator) and Atlas II HF CRT-D (cardiac resynchronization therapy defibrillator) devices are capable of delivering unsurpassed energy, giving added security to patients whose hearts are especially difficult to defibrillate.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
The i-STAT BNP cartridge is a point of care diagnostic test used to assess the level of BNP (brain naturietic peptide) ...
The Proxis Embolic Protection System is the first proximal embolic protection device designed for coronary applications.
The Encompass’ standards-based DVD-R archiving technology allows years of patient cardiology studies to be stored in a ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Targeted Renal Therapy (TRT) with the Benephit CV Infusion System from FlowMedica Inc. is an alternative to systemic intravenous (IV) infusion of medications to address kidney dysfunction related to a number of conditions. TRT is a novel technology that enables the infusion of medications and other therapeutic agents directly into the kidneys via the renal arteries.
Offering a combination of perfusion and function information in a single nuclear stress test, Lantheus Medical Imaging's Cardiolite kit for the preparation of technetium Tc99m sestamibi for injection enables physicians to assess patient risk and optimize patient management.
A new suite of cardiovascular workflow tools, ComPACSVersion 9 provides unequalled support of legacy ultrasound systems ...
September 18, 2006
